DANISH PHARMA FIRM OPENS CHINA PLANT
December 1st, 2012
BY KEITH NUTHALL
DENMARK-based pharmaceutical firm Lundbeck has announced that it has finished construction of its first factory in China, in the XEDA International Industrial Park, Tianjin. The plant is to initially focus on producing Alzheimer's disease treatments, repackaging Lundbeck's Ebixa medicine for the Chinese market.
A company communiqué has stressed the investment "demonstrates Lundbeck's long term commitment to China" and "will ensure better control of the supply chain in the Chinese market."
Looking ahead, Herman Santoni, ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.